Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
ALLOS THERAPEUTICS INC (ALTH)
Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
09/05/2012 | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Purchase | Common Stock | 130.9M | $1.82 | $238.2M | | 09/05/2012 |
09/04/2012 | STOUT DAVID M | Director | Other | Common Stock | 35k | $1.82 | $63.7k | | 09/04/2012 |
09/04/2012 | LEFF JONATHAN S | Director | Other | Common Stock | 55k | $1.82 | $100.1k | | 09/04/2012 |
09/04/2012 | BENNETT BRUCE K JR | VP, Pharmaceutical Operations | Other | Common Stock | 148.5k | $1.82 | $270.2k | | 09/04/2012 |
09/04/2012 | BERNS PAUL L | CEO | Other | Common Stock | 1.2M | $1.82 | $2.2M | | 09/04/2012 |
09/04/2012 | Graboyes Marc H | SVP, General Counsel | Other | Common Stock | 542k | $1.82 | $986.5k | | 09/04/2012 |
09/04/2012 | Clark David C | VP, Finance | Other | Common Stock | 207.1k | $1.82 | $376.9k | | 09/04/2012 |
09/04/2012 | LATTS JEFFREY | Director | Other | Common Stock | 55k | $1.82 | $100.1k | | 09/04/2012 |
09/04/2012 | HOFFMAN STEPHEN J | Director | Other | Common Stock | 92k | $1.82 | $167.4k | | 09/04/2012 |
09/04/2012 | HOFFMAN STEPHEN J | Director | Other | Common Stock | 472.9k | $1.82 | $860.6k | Stephen J Hoffman 2009 Revocable Trust | 09/04/2012 |
09/04/2012 | HOFFMAN STEPHEN J | Director | Other | Common Stock | 200 | $1.82 | $364 | Custodial Account For Elizabeth Hoffman | 09/04/2012 |
09/04/2012 | TURNER JOSEPH L | Director | Other | Common Stock | 55k | $1.82 | $100.1k | | 09/04/2012 |
09/04/2012 | Morris Charles Q | Chief Medical Officer | Other | Common Stock | 655k | $1.82 | $1.2M | | 09/04/2012 |
09/04/2012 | Schick Michael E | VP, Sales and Marketing | Other | Common Stock | 285.1k | $1.82 | $518.9k | | 09/04/2012 |
09/04/2012 | Goldsmith Bruce A | SVP, Corporate Development | Other | Common Stock | 346.9k | $1.82 | $631.4k | | 09/04/2012 |
09/04/2012 | GONZALO CECILIA | Director | Other | Stock Options (Right to Buy) | 25k | $1.39 | $34.8k | | 09/04/2012 |
07/11/2012 | Schick Michael E | VP, Sales and Marketing | Sale | Common Stock | 697 | $1.78 | $1.2k | | 07/11/2012 |
04/27/2012 | Morris Charles Q | Chief Medical Officer | Sale | Common Stock | 8k | $1.81 | $14.4k | | 04/27/2012 |
04/27/2012 | Morris Charles Q | Chief Medical Officer | Sale | Common Stock | 8k | $1.81 | $14.4k | | 04/27/2012 |
04/27/2012 | BENNETT BRUCE K JR | VP, Pharmaceutical Operations | Purchase | Common Stock | 1.1k | $1.22 | $1.3k | | 04/27/2012 |
03/01/2012 | BENNETT BRUCE K JR | VP, Pharmaceutical Operations | Sale | Common Stock | 3k | $1.50 | $4.5k | | 02/28/2012 |
03/01/2012 | BERNS PAUL L | CEO | Sale | Common Stock | 21.5k | $1.48 | $31.8k | | 02/28/2012 |
03/01/2012 | Clark David C | VP, Finance | Sale | Common Stock | 3.4k | $1.50 | $5.1k | | 02/28/2012 |
03/01/2012 | Graboyes Marc H | SVP, General Counsel | Sale | Common Stock | 9.6k | $1.48 | $14.3k | | 02/28/2012 |
03/01/2012 | Morris Charles Q | Chief Medical Officer | Sale | Common Stock | 10.3k | $1.48 | $15.2k | | 02/28/2012 |
03/01/2012 | Goldsmith Bruce A | SVP, Corporate Development | Sale | Common Stock | 4.5k | $1.50 | $6.7k | | 02/28/2012 |
03/01/2012 | Schick Michael E | VP, Sales and Marketing | Sale | Common Stock | 4k | $1.48 | $5.9k | | 02/28/2012 |
02/29/2012 | Schick Michael E | VP, Sales and Marketing | Sale | Common Stock | 3.9k | $1.52 | $5.9k | | 02/28/2012 |
02/29/2012 | Goldsmith Bruce A | SVP, Corporate Development | Sale | Common Stock | 4.5k | $1.52 | $6.9k | | 02/28/2012 |
02/29/2012 | Morris Charles Q | Chief Medical Officer | Sale | Common Stock | 10.2k | $1.52 | $15.5k | | 02/28/2012 |
02/29/2012 | Morris Charles Q | Chief Medical Officer | Sale | Common Stock | 10.2k | $1.52 | $15.5k | | 02/28/2012 |
02/29/2012 | Graboyes Marc H | SVP, General Counsel | Sale | Common Stock | 9.4k | $1.52 | $14.4k | | 02/28/2012 |
02/29/2012 | Clark David C | VP, Finance | Sale | Common Stock | 3.4k | $1.52 | $5.2k | | 02/28/2012 |
02/29/2012 | BERNS PAUL L | CEO | Sale | Common Stock | 21.2k | $1.52 | $32.2k | | 02/28/2012 |
02/29/2012 | BENNETT BRUCE K JR | VP, Pharmaceutical Operations | Sale | Common Stock | 3k | $1.53 | $4.6k | | 02/28/2012 |
|
|